Advance the clinical development of its OraQuick Ebola rapid antigen test.
Contract Awarded for Advance the clinical development of its OraQuick Ebola rapid antigen test.
Contract Award Date : Oct 2015
The US Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response's Biomedical Advanced Research and Development Authority (BARDA) has awarded the contract to OraSure to develop its rapid Ebola test.
Under the three year and multi-phased contract, the company will receive an initial payment of $1.8m, as well as an additional $8.6m to fund certain clinical and regulatory activities.
The company uses its OraQuick technology platform to develop the rapid Ebola test, which is earlier used in the development of the firm's rapid HIV and HCV test kits.
Earlier this year, the company completed the design of a prototype device that is said to deliver analytical performance similar to laboratory PCR tests when assessed on stored samples from infected patients.
Contractor name : ORASURE TECHNOLOGIES
Contractor address : 220 East First Street
Bethlehem, PA 18015
In the U.S.:
Implementing agency : The US Department of Health and Human Services (HHS)
200 Independence Avenue, S.W.
Washington, D.C. 20201
Toll Free Call Center: 1-877-696-6775
Url : www.hhs.gov/
Country :United States
Url : www.orasure.com/
[c] 2015 Al Bawaba (Albawaba.com) Provided by SyndiGate Media Inc. ( Syndigate.info ).
|Printer friendly Cite/link Email Feedback|
|Date:||Oct 23, 2015|
|Previous Article:||217 heavy-duty 40 foot Xcelsior(A), compressed natural gas ("CNG") transit buses.|
|Next Article:||Provide agile acquisition, systems engineering and logistics services for the U.S. Army Program Executive Office (PEO) Soldier.|